Skip to main content
NCBI home page
Applied Microbiology logoLink to Applied Microbiology
. 1971 Apr;21(4):710–717. doi: 10.1128/am.21.4.710-717.1971

In Vitro Studies of Semisynthetic α- (Substituted-Ureido) Penicillins

Gerald P Bodey 1,1, Dorothy Stewart 1
PMCID: PMC377261  PMID: 4930281

Abstract

The activity of three α-(substituted-ureido) penicillins was evaluated in vitro against 599 clinical isolates of gram-negative bacilli, by use of the broth-dilution technique. At a concentration of 12.5 μg or less/ml, BL-P1597 inhibited 90% of isolates of Pseudomonas sp., 56% of Enterobacter sp., 67% of indole-positive Proteus spp., 72% of Escherichia coli, and 85% of Proteus mirabilis. BL-P1654 had similar activity, whereas BL-P1532 was much less active. At a concentration of 25 μg or less/ml, BL-P1597 also inhibited nearly 60% of isolates of Klebsiella sp. and nearly 40% of Serratia sp. BL-P1597 and BL-P1654 were as active as ampicillin and carbenicillin against E. coli and P. mirabilis. They were less active than carbenicillin against indole-positive Proteus spp. Both drugs were substantially more active than carbenicillin against Pseudomonas sp. A strain of Pseudomonas sp. which developed resistance to carbenicillin also developed resistance to the α-(substituted-ureido) penicillins simultaneously.

Full text

PDF
710

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acred P., Brown D. M., Knudsen E. T., Rolinson G. N., Sutherland R. New semi-synthetic penicillin active against Pseudomonas pyocyanea. Nature. 1967 Jul 1;215(5096):25–30. doi: 10.1038/215025a0. [DOI] [PubMed] [Google Scholar]
  2. Bodey G. P., Rodriguez V., Luce J. K. Carbenicillin therapy of gram-negative bacilli infections. Am J Med Sci. 1969 Jun;257(6):408–414. doi: 10.1097/00000441-196906000-00007. [DOI] [PubMed] [Google Scholar]
  3. Bodey G. P., Stewart D. In vitro studies of a new semisynthetic penicillin, 6-(d-alpha-sulfoaminophenylacetamido)-penicillanic acid. Appl Microbiol. 1969 Jul;18(1):76–79. doi: 10.1128/am.18.1.76-79.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bodey G. P., Terrell L. M. In vitro activity of carbenicillin against gram-negative bacilli. J Bacteriol. 1968 May;95(5):1587–1590. doi: 10.1128/jb.95.5.1587-1590.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Darrell J. H., Waterworth P. M. Carbenicillin resistance in Pseudomonas aeruginosa from clinical material. Br Med J. 1969 Jul 19;3(5663):141–143. doi: 10.1136/bmj.3.5663.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. HERSH E. M., BODEY G. P., NIES B. A., FREIREICH E. J. CAUSES OF DEATH IN ACUTE LEUKEMIA: A TEN-YEAR STUDY OF 414 PATIENTS FROM 1954-1963. JAMA. 1965 Jul 12;193:105–109. doi: 10.1001/jama.1965.03090020019005. [DOI] [PubMed] [Google Scholar]
  7. Lowbury E. J., Lilly H. A., Kidson A., Ayliffe G. A., Jones R. J. Sensitivity of Pseudomonas aeruginosa to antibiotics: emergence of strains highly resistant to carbenicillin. Lancet. 1969 Aug 30;2(7618):448–452. doi: 10.1016/s0140-6736(69)90163-9. [DOI] [PubMed] [Google Scholar]
  8. MacLowry J. D., Marsh H. H. Semiautomatic microtechnique for serial dilution-antibiotic sensitivity testing in the clinical laboratory. J Lab Clin Med. 1968 Oct;72(4):685–687. [PubMed] [Google Scholar]
  9. Price K. E., Leitner F., Misiek M., Chisholm D. R., Pursiano T. A. BL-P 1654, a new broad-spectrum penicillin with marked antipseudomonal activity. Antimicrob Agents Chemother (Bethesda) 1970;10:17–29. [PubMed] [Google Scholar]
  10. Van Scoy R. E., Warren E., Washington J. A., 2nd In vitro antimicrobial activity of a new semisyntheti penicillin, BL-P 1654 (6-(R- -(guanylureido) phenylacetamido)-penicillanic acid). Antimicrob Agents Chemother (Bethesda) 1970;10:12–16. [PubMed] [Google Scholar]

Articles from Applied Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES